Latest Publications

Prognostic impact of cytogenetic alterations in newly diagnosed acute myeloid leukemia treated with risk-adapted protocols

Long-term results from the AGILE study of azacitidine plus ivosidenib vs placebo in newly diagnosed IDH1-mutated AML

Proteins of the cancer cell secretome induce the protumoral microenvironment of diffuse intrinsic pontine glioma

Cytokine-driven cancer immune evasion mechanisms

Latest news

The Josep Carreras Institute promotes the development of mRNA-based therapies for Rett Syndrome in collaboration with Bionure

July 30, 2025

The Josep Carreras Institute promotes the development of mRNA-based therapies for Rett Syndrome in collaboration with Bionure

New research programme to tackle childhood leukaemia at the Josep Carreras Institute

July 24, 2025

New research programme to tackle childhood leukaemia at the Josep Carreras Institute

The Communication Unit of the Josep Carreras Institute is accredited as a Scientific Culture and Innovation Unit

July 23, 2025

The Communication Unit of the Josep Carreras Institute is accredited as a Scientific Culture and Innovation Unit

Epigenetics on demand to tackle inflammatory diseases

July 17, 2025

Epigenetics on demand to tackle inflammatory diseases

A new cell therapy for leukaemia shows high efficacy and safety in the laboratory

July 07, 2025

A new cell therapy for leukaemia shows high efficacy and safety in the laboratory

A new drug developed in Spain shows great potential against Rett Syndrome

June 26, 2025

A new drug developed in Spain shows great potential against Rett Syndrome

Dr. Mar Mallo: We recommend the use of Optical Genome Mapping in the diagnosis of leukaemia

June 25, 2025

Dr. Mar Mallo: We recommend the use of Optical Genome Mapping in the diagnosis of leukaemia

Locations

IJC Josep Trueta

Who we are, in data

430

4 programs

39 Research Groups

372 Researchers and technicians

58 Management staff

272 Women

157 Men

1 Others